Regional dissemination of Acinetobacter species harbouring metallo-β-lactamase genes in Japan

Clinical Microbiology and Infection

Volumn 19, Issue 8, 2013, Pages 729-736

  Yamamoto, M ^a   Nagao, M ^a   Matsumura, Y ^a   Hotta, G ^a   Matsushima, A ^a   Ito, Y ^b   Takakura, S ^a   Ichiyama, S ^a  

^a Department of Clinical Laboratory Medicine ^*  (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbapenemase; Class 1 integron; Gene cassettes; Regional epidemiology; Species level identification

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BETA LACTAMASE IMP 1; BETA LACTAMASE IMP 19; BETA LACTAMASE IMP11; BETA LACTAMASE OXA 23 LIKE; BETA LACTAMASE OXA 24 LIKE; BETA LACTAMASE OXA 51 LIKE; BETA LACTAMASE OXA 58 LIKE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; RNA 23S; SULTAMICILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER BEREZINIAE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; INTEGRON; JAPAN; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER; UNCLASSIFIED ACINETOBACTER;

EID: 84880508378     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12013     Document Type: Article

References (26)

1. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-836.
2. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 2009; 63: 55-59.
3. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010; 65: 233-238.
4. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect Dis 2011; 11: 381-393.
5. Lee K, Kim CK, Hong SG et al. Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases. Int J Antimicrob Agents 2010; 36: 259-263.
6. Lin YC, Sheng WH, Chen YC, Chang SC, Hsia KC, Li SY. Differences in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Int J Antimicrob Agents 2010; 35: 439-443.
7. Lee YT, Huang LY, Chiang DH et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents 2009; 34: 580-584.
8. Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P. First identification of VIM-4 metallo-beta-lactamase in Acinetobacter spp. Clin Microbiol Infect 2008; 14: 289-290.
9. Chu YW, Afzal-Shah M, Houang ET et al. IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 2001; 45: 710-714.
10. IMP-19 among Acinetobacter species in Japan. J Antimicrob Chemother 2011; 66: 2480-2483.
11. Arakawa Y, Shibata N, Shibayama K et al. Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000; 38: 40-43.
12. La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006; 44: 827-832.
13. Karah N, Haldorsen B, Hegstad K et al. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother 2011; 66: 738-744.
14. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005; 43: 1632-1639.
15. Seifert H, Dolzani L, Bressan R et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
16. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 2010; 5: e10034.
17. Clinical and Laboratory Standards Institute (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 9th edn. Document M07-A9. Wayne, PA, USA: CLSI.
18. Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing; Twenty-Second Informational Supplement M100-S22. Wayne, PA, USA: CLSI.
19. Levesque C, Piche L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-191.
20. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50: 1442-1448.
21. Nemec A, Krizova L, Maixnerova M et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011; 162: 393-404.
22. Nemec A, Musilek M, Sedo O et al. Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol 2010; 60: 896-903.
23. Nemec A, Musilek M, Maixnerova M et al. Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol 2009; 59: 118-124.
24. Adams-Haduch JM, Onuoha EO, Bogdanovich T et al. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 2011; 49: 3849-3854.
25. Endo S, Yano H, Hirakata Y et al. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. J Antimicrob Chemother 2012; 67: 1623-1626.
26. Wang H, Guo P, Sun H et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007; 51: 4022-4028.